前往化源商城

Toxicology 2014-09-02

Interindividual variation in response to xenobiotic exposure established in precision-cut human liver slices.

Marlon J A Jetten, Sandra M Claessen, Cornelis H C Dejong, Agustin Lahoz, José V Castell, Joost H M van Delft, Jos C S Kleinjans

文献索引:Toxicology 323 , 61-9, (2014)

全文:HTML全文

摘要

Large differences in toxicity responses occur within the human population. In this study we evaluate whether interindividual variation in baseline enzyme activity (EA)/gene expression (GE) levels in liver predispose for the variation in toxicity responses by assessing dose-response relationships for several prototypical hepatotoxicants. Baseline levels of cytochrome-P450 (CYP) GE/EA were measured in precision-cut human liver slices. Slices (n=4-5/compound) were exposed to a dose-range of acetaminophen, aflatoxin B1, benzo(α) pyrene or 2-nitrofluorene. Interindividual variation in induced genotoxicity (COMET-assay and CDKN1A/p21 GE) and cytotoxicity (lactate dehydrogenase-leakage), combined with NQO1- and GSTM1-induced GE-responses for oxidative stress and GE-responses of several CYPs was evaluated. The benchmark dose-approach was applied as a tool to model exposure responses on an individual level. Variation in baseline CYP levels, both GE and EA, can explain variation in compound exposure-responses on an individual level. Network analyses enable the definition of key parameters influencing interindividual variation after compound exposure. For 2-nitrofluorene, this analysis suggests involvement of CYP1B1 in the metabolism of this compound, which represents a novel finding. In this study, GSTM1 which is known to be highly polymorphic within the human population, but so far could not be linked to toxicity in acetaminophen-poisoned patients, is suggested to cause interindividual variability in acetaminophen-metabolism, dependent on the individual's gene expression-responses of CYP-enzymes. This study demonstrates that using interindividual variation within network modelling provides a source for the definition of essential and even new parameters involved in compound-related metabolism. This information might enable ways to make more quantitative estimates of human risks. Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

相关化合物

结构式 名称/CAS号 全部文献
氢氧化钠 结构式 氢氧化钠
CAS:1310-73-2
氯化钠 结构式 氯化钠
CAS:7647-14-5
氨基甲烷 结构式 氨基甲烷
CAS:74-89-5
对乙酰氨基苯酚 结构式 对乙酰氨基苯酚
CAS:103-90-2
黄曲霉素 B1 结构式 黄曲霉素 B1
CAS:1162-65-8
二甲基亚砜 结构式 二甲基亚砜
CAS:67-68-5
无水氯化钙 结构式 无水氯化钙
CAS:10043-52-4
3-乙基-2,4-戊烷二酮 结构式 3-乙基-2,4-戊烷二酮
CAS:1540-34-7
L-谷氨酰胺 结构式 L-谷氨酰胺
CAS:56-85-9
碳酸氢钠 结构式 碳酸氢钠
CAS:144-55-8